CASEY RODENBAUGH: Open Payments
NPI 1184344004 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 25 payments from 12 companies in 2025. Trend: 2023 $826 · 2024 $710 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $110 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $97 |
| Biogen, Inc. | 3 | $86 |
| Medtronic, Inc. | 2 | $64 |
| Exeltis, USA Inc. | 2 | $28 |
| Organon LLC | 2 | $27 |
| Baxter Healthcare | 1 | $25 |
| SHIELD THERAPEUTICS INC | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $17 |
Products named: Veozah, ZURZUVAE, INTERSTIM, SLYND, TISSEEL, ACCRUFER, MYFEMBREE, ABRYSVO.
Industry payments across AZ — which companies pay providers there.
